Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue American Journal of Respiratory and Critical Care Medicine Année : 2006

Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy.

Résumé

RATIONALE: Hypoxia-induced pulmonary hypertension involves hypoxia-inducible factor-1alpha (HIF-1alpha) activation as well as elevated resting calcium levels. Cyclosporin A (CsA) inhibits calcium-induced calcineurin activation and blocks the stabilization of HIF-1alpha in cultured cells. OBJECTIVES: We hypothesized that treatment of rats with CsA would prevent HIF-1-dependent gene transcription, lower specific responses to acute hypoxia, and prevent pulmonary hypertension and right ventricle hypertrophy resulting from prolonged exposure to hypoxia. METHODS: Acute and chronic responses to hypoxia were studied in rats treated or not treated with CsA (25 mg x kg(-1) x d(-1)). MEASUREMENTS: Transcript levels of genes encoding the serotonin transporter or four HIF-1 target genes, in rats exposed for 6 h to ambient hypoxia, treated or not by CsA, were measured. In vivo hemodynamics, hematocrit, and heart morphologic characteristics were assessed in rats subjected to hypoxia for 3 wk, treated or not treated with CsA. Changes in mRNA levels of the modulatory calcineurin-interacting protein-1 (MCIP-1) were used as a sensitive indicator of calcineurin activity in lung and heart. MAIN RESULTS: Acute exposure to hypoxia led to a marked increase in mRNA levels of serotonin transporter, modulatory calcineurin-interacting protein-1, and HIF-1 target genes, which was blunted by CsA treatment. Prolonged exposure to hypoxia raised right ventricle pressure, induced right ventricle hypertrophy, and activated cardiac calcineurin, effects that were fully prevented by CsA treatment. CONCLUSIONS: These results suggest that CsA prevents hypoxia-induced pulmonary hypertension and right ventricle hypertrophy, either by inhibiting HIF-1 transcriptional activity in lung, by decreasing calcineurin activity in lung and heart, by direct effects of CsA, or by a combination of these factors.
Fichier non déposé

Dates et versions

inserm-00410546 , version 1 (10-09-2009)

Identifiants

Citer

Nathalie Koulmann, Valérie Novel-Chaté, André Peinnequin, Rachel Chapot, Bernard Serrurier, et al.. Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy.. American Journal of Respiratory and Critical Care Medicine, 2006, 174 (6), pp.699-705. ⟨10.1164/rccm.200512-1976OC⟩. ⟨inserm-00410546⟩
156 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More